Cargando…

Successful treatment of hairy cell leukemia variant with obinutuzumab

Detalles Bibliográficos
Autores principales:	Al-Sarayfi, Diana, Meeuwes, Freek O., Munnink, Thijs Oude, Plattel, Wouter, Rosati, Stefano, Matutes, Estella, Nijland, Marcel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810450/ https://www.ncbi.nlm.nih.gov/pubmed/34086065 http://dx.doi.org/10.1007/s00277-021-04559-z

Ejemplares similares

P1161: THERAPY AND OUTCOME IN RELAPSED AND REFRACTORY PERIPHERAL T-CELL LYMPHOMA: A CONTEMPORARY AND NATIONWIDE POPULATION-BASED STUDY IN THE NETHERLANDS.
por: Brink, Mirian, et al.
Publicado: (2023)

Variant form of hairy cell leukemia
por: Wiber, Margaux, et al.
Publicado: (2019)

A Unique Hairy Cell Leukemia Variant
por: Jian, Charles, et al.
Publicado: (2016)

Hairy cell leukemia variant: the importance of differential diagnosis
por: Rudolf-Oliveira, Renata Cristina Messores, et al.
Publicado: (2015)

Toxoplasmic Encephalitis with Untreated Hairy Cell Leukemia Variant
por: Ikebe, Taichi, et al.
Publicado: (2016)

Obinutuzumab treatment in the elderly patient with chronic lymphocytic leukemia
por: Seiter, Karen, et al.
Publicado: (2015)

Clinical application of obinutuzumab for treating chronic lymphocytic leukemia
por: Luan, Chunyan, et al.
Publicado: (2019)

Current and Emerging Therapeutic Options for Hairy Cell Leukemia Variant
por: Liu, Qiuying, et al.
Publicado: (2021)

New developments in the treatment of chronic lymphocytic leukemia: role of obinutuzumab
por: Shah, Arpita
Publicado: (2015)

Targeted treatment for chronic lymphocytic leukemia: clinical potential of obinutuzumab
por: Smolej, Lukáš
Publicado: (2014)

Obinutuzumab in chronic lymphocytic leukemia: design, development and place in therapy
por: Al-Sawaf, Othman, et al.
Publicado: (2017)

Retreatment with obinutuzumab: An addition to the therapeutic landscape of chronic lymphocytic leukemia
por: Khurana, Sharad, et al.
Publicado: (2019)

PB2688: OPIOID USE REDUCTION BY OXYCODONE MORPHINE FORMULARY SWITCH
por: Hazenberg, Carin, et al.
Publicado: (2023)

Successful Use of Intravenous Immunoglobulins in an Obinutuzumab-related Acute Thrombocytopenia
por: Haage, Tobias R., et al.
Publicado: (2022)

Evaluation and associated risk factors for neutropenia with venetoclax and obinutuzumab in the treatment of chronic lymphocytic leukemia
por: Samuels, Courtney, et al.
Publicado: (2021)

Clonal dynamics in a composite chronic lymphocytic leukemia and hairy cell leukemia‐variant
por: Locher, Maurus, et al.
Publicado: (2020)

Remarkable Response of Hairy Cell Leukemia Variant to Single-Agent Cladribine
por: Otieno, Steve B, et al.
Publicado: (2022)

Genomics of Hairy Cell Leukemia
por: Tiacci, Enrico, et al.
Publicado: (2017)

Difference of genomic copy numbers alterations between hairy cell leukemia-variant and classical hairy cell leukemia: a pilot retrospective study in Chinese
por: Zhang, Rui, et al.
Publicado: (2020)

Profile of obinutuzumab for the treatment of patients with previously untreated chronic lymphocytic leukemia
por: Hill, Brian T, et al.
Publicado: (2015)

Clinical role of obinutuzumab in the treatment of naive patients with chronic lymphocytic leukemia
por: Cerquozzi, Sonia, et al.
Publicado: (2015)

Obinutuzumab in a patient with chronic lymphocytic leukemia-associated paraneoplastic pemphigus
por: Freund, Johanna, et al.
Publicado: (2022)

Immunophenotypic Analysis of Hairy Cell Leukemia (HCL) and Hairy Cell Leukemia-like (HCL-like) Disorders
por: Maitre, Elsa, et al.
Publicado: (2022)

Deciphering Genetic Alterations of Hairy Cell Leukemia and Hairy Cell Leukemia-like Disorders in 98 Patients
por: Maitre, Elsa, et al.
Publicado: (2022)

The value of thymus and activation related chemokine immunohistochemistry in classic Hodgkin lymphoma diagnostics
por: Kilsdonk, Melvin, et al.
Publicado: (2022)

BRAF Mutation in Hairy Cell Leukemia
por: Ahmadzadeh, Ahmad, et al.
Publicado: (2014)

Hairy cell leukemia – immunotargets and therapies
por: Basheer, Faisal, et al.
Publicado: (2014)

Skeletal involvement of hairy cell leukemia
por: Durot, Eric, et al.
Publicado: (2018)

Time to Cure Hairy Cell Leukemia
por: Levy, Ilana, et al.
Publicado: (2017)

An Unusual Presentation of Hairy Cell Leukemia
por: Gajendra, Smeeta, et al.
Publicado: (2019)

Skin changes in hairy cell leukemia
por: Robak, Ewa, et al.
Publicado: (2020)

The Biology of Classic Hairy Cell Leukemia
por: Bohn, Jan-Paul, et al.
Publicado: (2021)

Obinutuzumab‐induced serum sickness following salvage therapy for chronic lymphocytic leukemia
por: Saba, Julie, et al.
Publicado: (2017)

Efficacy and Safety of Tirabrutinib and Idelalisib With or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia
por: Kutsch, Nadine, et al.
Publicado: (2022)

Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemia
por: Al-Sawaf, Othman, et al.
Publicado: (2023)

Novel targeted treatments in hairy cell leukemia and other hairy cell-like disorders
por: Maitre, Elsa, et al.
Publicado: (2022)

A Case of Hairy Cell Leukemia Variant: Literature Analysis With Focus on Unmet Needs
por: Kumar Upadhyay, Amitabh, et al.
Publicado: (2023)

First-line treatment of chronic lymphocytic leukemia with ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab: final analysis of the randomized, phase III iLLUMINATE trial
por: Moreno, Carol, et al.
Publicado: (2022)

Complete recovery of pyoderma gangrenosum after successful treatment of underlying hairy cell leukemia with cladribine
por: Tombak, Anıl, et al.
Publicado: (2015)

Obinutuzumab: A Novel Anti-CD20 Monoclonal Antibody for Chronic Lymphocytic Leukemia
por: Evans, Sarah S., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_tprub2j3se89ftiru6g4lmld48